NCT01177059View on ClinicalTrials.gov

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 6, 2004

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

HIV-1

Interventions

GENETIC

OZ1 transduced cells

Long term follow up of previously infused OZ1 transduced cells

Trial Locations (6)

Unknown

Los Angeles

San Francisco

New York

Darlinghurst

Surry Hills

Sydney

All Listed Sponsors

lead

Janssen-Cilag Pty Ltd

INDUSTRY

NCT01177059 - Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial | Biotech Hunter | Biotech Hunter